LYCIA THERAPEUTICS

Welcome to the Brand page for “LYCIA THERAPEUTICS”, which is offered here for Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; gene therapy products, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; pharmaceutical preparations for use in gene therapy; biological preparations for use in gene therapy; viruses for therapeutic purposes, for gene therapy and antivirals;therapeutics;.

Its status is currently believed to be active. Its class is unavailable. “LYCIA THERAPEUTICS” is believed to be currently owned by “Lycia Therapeutics, Inc.”